A Discussion of COPD Surveillance Data

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Earl S. Ford, MD, MPH and David M. Mannino, MD, FCCP, discuss their study of surveillance results for COPD in the United States from 1999 to 2011 with CHEST podcast editor D. Kyle Hogarth, MD, FCCP.

To listen to this podcast, click here.
Related Articles
Patients with chronic obstructive pulmonary disease who consume beetroot juice have less trouble exercising.
Novartis announced that it has submitted New Drug Applications to the FDA for QVA149 and NVA237, investigational drugs for the long-term maintenance treatment of chronic obstructive pulmonary disease, following positive results from phase 3 trials of the drugs.
Rhinovirus infection tends to aggravate other conditions in the elderly.
Tiotropium, a once-daily inhaled long-acting anticholinergic bronchodilator, provides airflow improvement for at least 24 hours in chronic obstructive pulmonary disease patients. Its use has been linked to fewer exacerbations, less dyspnea, and improved quality of life.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$